Aclaris Therapeutics is a physician-led biopharmaceutical company focused on dermatological and immuno-inflammatory diseases. The company's commercial product, ESKATA (hydrogen peroxide) topical solution, 40% (w/w), or ESKATA, is a proprietary formulation of high-concentration hydrogen peroxide topical solution for raised seborrheic keratosis, a common non-malignant skin tumor. The company has acquired RHOFADE (oxymetazoline hydrochloride) cream, 1%, or RHOFADE, which includes a license to certain intellectual property for RHOFADE, from Allergan Sales, LLC. RHOFADE has been approved for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. The company's clinical pipeline includes: ARQ 531, which is a reversible dual inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; Miransertib, which is a selective inhibitor of protein kinase B (AKT) in combination with the hormonal therapy, anastrozole; ARQ 751, which is a selective inhibitor of AKT for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase and tensin homolog (PTEN) mutations or that are PTEN null; and Derazantinib, which is a multi-kinase inhibitor.

Capital Senior Living is an operator of senior housing communities. The company provides senior living services, including independent living services, which are provided to seniors who do not yet need assistance, but who prefer the physical and psychological comfort of a residential community that provides health care and other services; assisted living services, which include personal care services, 24-hour staffing, support services, and supplemental services; and memory care services, which maintain programs and living accomodations for residents with certain forms of dementia. The company makes home care services available to clients at its senior housing communities through third-party providers.

Corvus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. The company develops small molecules that are designed to selectively inhibit the binding of immunosuppressive adenosine to either A2A receptors or to A2B receptors. The company's initial product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine. The company's second clinical product candidate, CPI-006, is an anti-CD73 monoclonal antibody that is designed to both inhibit the production of adenosine and stimulate various immune cells. The company's third clinical product candidate, CPI-818, is a selective, covalent inhibitor of ITK.

Dova Pharmaceuticals is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. The United States Food and Drug Administration has approved DOPTELET (avatrombopag), which is an orally administered thrombopoietin receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure. The company is also conducting a trial in chemotherapy-induced thrombocytopenia.

Hooker Furniture is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture and fabric-upholstered furniture. The company is organized into two segments: Hooker Branded, which includes Hooker Casegoods that covers a range of design categories and includes home entertainment, home office, accent, dining and bedroom furniture in the upper-medium price points sold under the Hooker Furniture brand; and Home Meridian, which includes Accentrics Home, home furnishings centered around a mix of pieces and materials that provide a take on home fashion, and Samuel Lawrence Furniture, focuses on offerings in bedroom, dining room, home office and youth furnishings.

Macerich is a self-administered and self-managed real estate investment trust. The company is involved in the acquisition, ownership, development, redevelopment, management and leasing of regional and community/power shopping centers. The company is the sole general partner of, and owns a majority of the ownership interests in, The Macerich Partnership, L.P. (the Operating Partnership). The Operating Partnership owns or has an ownership interest in regional shopping centers and community/power shopping centers. The company conducts all of its operations through the Operating Partnership and its management companies, including Macerich Property Management Company, LLC and Macerich Management Company.

Motus GI Holdings is a development stage company. The company has developed the Pure-Vu system, a medical device. The Pure-Vu System is indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard and slim colonoscopes to enable cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter.

Tejon Ranch is a real estate development and agribusiness company. The company's segments are: Real Estate-Commercial/Industrial, which is involved in building, land lease activities, and land and building sales; Real Estate-Resort/Residential, which is involved in the land entitlement and development process internally and through a joint venture; mineral resources, which includes oil and gas royalty leases, rock and aggregate mining leases, a lease with National Cement and sales of water; Farming Operations, which is engaged in the sale of wine grapes, almonds and pistachios; and Ranch Operations, which consists of game management and ancillary land uses such as grazing leases and filming.